This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  

Life science leaders converge at collaboration event hosted by The Oxford Science Park

Life science leaders converge at collaboration event hosted by The Oxford Science Park

30 Sep 2024

Last week The Oxford Science Park (TOSP) hosted an event bringing together leaders from the life sciences industry, Oxford’s universities, and key figures from the city’s innovation ecosystem to discuss ways to leverage Oxford’s strengths in collaboration. Those attending the event, which took place at Magdalen College, heard from the University of Oxford’s Vice-Chancellor, Professor Irene Tracey; Dr Kay Penicud, VP Head of Research... Read more

Theolytics awarded significant £2M Transforming Cancer Therapeutics grant from Innovate UK

Theolytics awarded significant £2M Transforming Cancer Therapeutics grant from Innovate UK

02 Sep 2024

Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic viral therapies, has been awarded £2M from Innovate UK’s prestigious Transforming Cancer Therapeutics grant funding competition to support the clinical development of its lead candidate THEO-260. This non-dilutive funding adds to the £19M raised earlier this year from a strong investor syndicate comprising M Ventures, Taiho Ventures, Epidarex Capital,... Read more

Exscientia and Recursion Enter Definitive Agreement

Exscientia and Recursion Enter Definitive Agreement

13 Aug 2024

Recursion and Exscientia plc have announced the companies have entered into a definitive agreement, combining Recursion, a leading clinical stage technology-enabled biotech company decoding biology to industrialize drug discovery, with Exscientia, a technology-driven clinical stage drug design and development company, committed to creating more effective medicines for patients, faster. Chris Gibson, Co-Founder and CEO of Recursion as well as... Read more

Ellison Institute expands to new building on The Oxford Science Park to accommodate growth

Ellison Institute expands to new building on The Oxford Science Park to accommodate growth

01 Aug 2024

The Ellison Institute of Technology Oxford (EIT) is expanding into Winchester House on The Oxford Science Park to accommodate for significant growth and an anticipated tripling in headcount over the coming years. The phased move, starting this month, will see the interdisciplinary research and development facility EIT taking full occupancy of Winchester House throughout the remainder of the year. Winchester House was built in 2008... Read more

Mace awarded contract to deliver The Daubeny Project at The Oxford Science Park

Mace awarded contract to deliver The Daubeny Project at The Oxford Science Park

22 Jul 2024

Mace has been awarded a £184 million contract to deliver the next expansion phase at The Oxford Science Park, The Daubeny Project. This landmark project will see the construction of three new state-of-the-art laboratory and office buildings, further cementing Oxford's position as a world-leading centre for scientific innovation. The expansion will add 400,500 sq ft of premium laboratory and office space to the park, addressing the critical... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More